Related Experiment Videos
Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit
D B Northridge1, A Shandall, A Rees
1Department of Cardiology, University Hospital of Wales, Cardiff.
Insights
Many patients undergoing coronary bypass surgery have lipid levels measured, but few with high cholesterol receive necessary interventions like medication or dietary advice. This highlights a gap in managing hyperlipidaemia post-surgery.
Area of Science:
- Cardiology
- Metabolic Disorders
- Health Services Research
Background:
- Hyperlipidaemia is a significant risk factor for coronary artery disease.
- Coronary artery bypass surgery (CABS) is a common intervention for severe coronary artery disease.
- Effective management of lipid levels post-CABS is crucial for long-term patient outcomes.
Purpose of the Study:
- To audit the detection and management of hyperlipidaemia in patients following coronary bypass surgery.
- To identify potential deficiencies in lipid management protocols after CABS.
Main Methods:
- Retrospective audit of 100 consecutive patients (mean age 61) who survived at least 3 months post-CABS.
- Review of case notes and computerized biochemistry records for lipid measurements and interventions.
- Analysis of lipid concentrations (total cholesterol, triglycerides) and recorded interventions (dietician referral, lipid-lowering drugs).
Main Results:
- 83% of patients had at least one lipid measurement during hospitalization.
- Median total cholesterol was 6.7 mmol/l; median triglycerides were 2.1 mmol/l.
- Only 30% were referred to a dietician, and 12% received lipid-lowering drugs, irrespective of lipid levels.
Conclusions:
- While lipid levels are frequently measured post-CABS, a substantial number of patients with hyperlipidaemia do not receive appropriate lipid-lowering interventions.
- There is a need to improve the systematic management of hyperlipidaemia in patients after coronary bypass surgery.
- Current practices may not fully leverage interventions to reduce secondary cardiovascular events in this patient population.
Objective:
To audit the detection and management of hyperlipidaemia in patients who have had coronary bypass surgery.
Patients:
100 consecutive patients (81 men), mean age 61, who had survived at least 3 months after coronary bypass surgery.
Methods:
Retrospective review of case notes and computerised biochemistry records.
Results:
83 patients had at least one lipid measurement in the hospital, and of the remaining 17 patients, 10 had undergone urgent or emergency surgery. The median (range) total cholesterol was 6.7 (4.0-11.7) mmol/l and the triglyceride concentration was 2.1 (0.6-18.4) mmol/l. Only 30 patients were referred to a dietician, and 12 were given a lipid lowering drug--these interventions were no more frequent in patients with a cholesterol concentration above than below the median.
Conclusions:
Although a high proportion of patients who undergo routine coronary bypass surgery have their plasma lipid concentrations measured, many patients with raised cholesterol concentrations, who would benefit from lipid lowering interventions, are not offered them.